mTOR pathway: a novel front in ovarian cancer precision therapeutics

Overview of attention for article published in Frontiers in Pharmacology, January 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 15 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,890 followers.

Nanotechnological synergy of mangiferin and curcumin in modulating PI3K/Akt/mTOR pathway: a novel front in ovarian cancer precision therapeutics https://t.co/GguVXnPCux

07 Jan 2024

Reply Repost Favourite

New Research: Nanotechnological synergy of mangiferin and curcumin in modulating PI3K/Akt/mTOR pathway: a novel front in ovarian cancer precision therapeutics https://t.co/7CJmz52GuR #pharmacology

05 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.